|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis:Results of a double-blind,placo-controlled phase Ⅱa trial of three dosage levels of CP-690,550 versus placebo显示文摘 | Kremer JM Bloom BJ Breedveld FC | | 0，，07： | 1 |
| 2 | Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis显示文摘 | Bloom BJ Alario AJ Miller LC | | 0，，02： | 1 |
| 3 | Felty syndrome complicating juvenile rheumatoid arthritis显示文摘 | Bloom BJ Smith P Alario AJ | | 0，，： | 1 |
| 4 | Soluble adhesion molecules in pediatric rheumatic diseases显示文摘 | Bloom BJ Miller LC Blier PR | 2002 | J Rheumatol2002，29，4： | 1 |
| 5 | Persistent elevation of fibrinD-dimer predicts longterm outcome in systemic juvenileidiopathic arthritis显示文摘 | Bloom BJ? Alario AJ Miller LC | 2009 | J Rheumatol2009，36，2： | 1 |
| 6 | Soluble adhesion molecules in pediatric rheumatic diseases显示文摘 | Bloom BJ Miller LC Blier PR | 2002 | J Rheumatol2002，29，4： | 1 |
| 7 | Peristent elevation of fibrin D-dimerpredicts longterm outcome in systemic juvenile idiopathic ar-thritis 显示文摘 | Bloom BJ Alario AJ Miller LC | 2009 | J Rheumatol2009，36，2： | 1 |
| 8 | Efficacy and safety of CE-224535, an antagonist of P2X7 receptor, in treatment of pa- tients with rheumatoid arthritis inadequately controlled by metho- trexate显示文摘 | STOCK TC BLOOM BJ WEI N | 2012 | JRheumatol2012，39，4： | 1 |
| 9 | Soluble adhesion molecules in juvenile rheumatoid arthritis显示文摘 | Bloom BJ Miller LC Tucker LB | 1999 | J Rheumatol1999，26，9： | 1 |
| 10 | Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic aarthritis显示文摘 | Bloom BJ Alario AJ Miller LC | 2009 | J Rheumatol2009，36，2： | 1 |
| 11 | Soluble intercellular adhesion molecule-1 and E-selection as markers of disease activity and endothelial activation in juvenile idiopathic arthritis 显示文摘 | Bloom BJ Nelson SM Eisenherg D | | J Rheumatol0，32，2： | 1 |
| 12 | Felty syndrome complicating juvenile rheumatoid arthritis 显示文摘 | Bloom BJ Smith P Alario A J | 1998 | J Pediatr Hematol Oncol1998，20，5： | 1 |
| 13 | Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis 显示文摘 | Bloom BJ Tucker LB Miller LC | 1998 | J Rheumatol1998，25，8： | 1 |
| 14 | Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis 显示文摘 | Bloom BJ Tucker LB Miller LC | 1998 | J Rheumatol1998，25，8： | 1 |
| 15 | The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo 显示文摘 | Kremer JM Bloom BJ Breedveld FC | 2009 | Arthritis Rheum2009，60，7： | 1 |
| 16 | The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis:tesults of a double-blind,placebo-controlled phase ?a trial of three dosage levels of CP-690 550 versus placebo显示文摘 | Kremer JM Bloom BJ Breedveld FC | 2009 | Arthritis Rheum2009，60，7： | 1 |
| 17 | Improved pain,physical functioning and health status in patients with rheumatoid arthritis treated with CP690 550,an orally active Janus kinase(JAK) inhibitor:results from a randomised,double blind,placebo-controlled trial显示文摘 | Coombs JH Bloom BJ Breedveld FC | 2010 | Ann Rheum Dis2010，69，2： | 1 |
| 18 | Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised,double-blind, placebo-controlled trial 显示文摘 | Coombs JH Bloom BJ Breedveld FC | 2010 | Ann Rheum Dis2010，69，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员